About
Sorrento Therapeutics is a clinical-stage biopharmaceutical company focused on developing therapies for cancer, pain management, and inflammatory diseases using antibody, cell therapy, and small molecule technologies.
Explore Sorrento Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.